CMS Announces FY 2015 New-Tech Add-On Payment Applicants
This article was originally published in The Gray Sheet
Among the latest round of applicants announced Dec. 26 for the hospital inpatient, new-technology add-on payments are five device makers: Boston Scientific (Watchman), CardioMEMS (Champion HF), Abbott Vascular (MitraClip), NeuroPace (RNS), and Aptus Endosystems (Heli-FX EndoAnchor).
You may also be interested in...
CMS agreed to grant new tech add-on payments to St. Jude’s CardioMEMS implantable heart failure monitoring system and Abbott’s MitraClip mitral valve repair system, but it took some convincing. The agency also granted an add-on for NeuroPace’s RNS responsive neurostimulator system to treat seizures.
The Medicare agency is questioning whether Boston Scientific’s Watchman stroke device or the CardioMEMS implantable heart failure monitor, championed by St. Jude Medical, can meet the “substantial clinical improvement” threshold to qualify for an inpatient new-technology add-on payment.
CMS proposes to grant new hospital inpatient payment categories for transcatheter valve replacements, a potential boon to Edwards’ and Medtronic’s devices. But the Medicare agency continues to stand firm against upgrading payment levels for Abbott’s MitraClip percutaneous mitral valve repair procedure.